PMDA — authorised 26 June 2017
- Marketing authorisation holder: Fuji Chemical Industries Co., Ltd.
- Status: approved
PMDA authorised Ethamolin on 26 June 2017
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 26 June 2017.
Fuji Chemical Industries Co., Ltd. holds the Japanese marketing authorisation.